Irritable Bowel Syndrome–A Potentially New Treatment at Last? – (06-28-00)



Irritable Bowel Syndrome–A Potentially New Treatment at Last?

They need to rephrase the title. The authors mean a new PHARMACEUTICAL treatment, because there have been many ways to treat IBS from a natural medicine standpoint using probiotics and diet as a start.

These studies provide encouraging news that tegaserod, by accelerating orocecal transit and especially colonic transit, may prove to be a benefit in patients with constipation-predominant IBS. It is obvious that further clinical studies on intestinal transit and secretion as well as the overall clinical efficacy of tegaserod in IBS are necessary. Nevertheless, this drug seems to have promise for patients with IBS.

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Diarrhea / Constipation / Irritable Bowel, Probiotic
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”